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of Target engagement  
in the Treatment of auditory  
hallucinations with Transcranial 
Direct current stimulation
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1 Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, United States, 2 Department of 
Biomedical Engineering, The City College of New York, City University of New York, New York, NY, United States
We use auditory verbal hallucinations (AVH) to illustrate the challenges in defining and 
assessing target engagement in the context of transcranial direct current stimulation 
(tDCS) for psychiatric disorders. We defined the target network as the cluster of regions 
of interest (ROIs) that are consistently implicated in AVH based on the conjunction of 
multimodal meta-analytic neuroimaging data. These were prescribed in the New York 
Head (a population derived model) and head models of four single individuals. We 
appraised two potential measures of target engagement, tDCS-induced peak electric 
field strength and tDCS-modulated volume defined as the percentage of the volume 
of the AVH network exposed to electric field magnitude stronger than the postulated 
threshold for neuronal excitability. We examined a left unilateral (LUL) montage targeting 
the prefrontal cortex (PFC) and temporoparietal junction (TPJ), a bilateral (BL) prefrontal 
montage, and a 2 ×  1 montage targeting the left PFC and the TPJ bilaterally. Using 
computational modeling, we estimated the peak electric field strength and modulated 
volume induced by each montage for current amplitudes ranging 1–4 mA. We found 
that the LUL montage was inferior to both other montages in terms of peak electric field 
strength in right-sided AVH-ROIs. The BL montage was inferior to both other montages 
in terms of modulated volume of the left-sided AVH-ROIs. As the modulated volume is 
non-linear, its variability between montages reduced for current amplitudes above 3 mA. 
These findings illustrate how computational target engagement for tDCS can be tailored 
to specific networks and provide a principled approach for future study design.
Keywords: auditory hallucinations, neuroimaging, computational modeling, transcranial direct current stimulation, 
schizophrenia
inTrODUcTiOn
Transcranial direct current stimulation (tDCS) is a non-invasive neuromodulation technique 
currently under evaluation for the treatment of neuropsychiatric conditions. tDCS involves the 
application of a weak electric current that flows through the brain from anodal to cathodal scalp 
electrodes. Proposed mechanisms of action for tDCS involve polarity-dependent changes in the 
resting membrane potential (depolarization at the anode and hyperpolarization at the cathode) and 
changes in synaptic plasticity (1–5).
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As the application of tDCS to neuropsychiatric disorders 
is expanding, the field has begun to recognize significant con-
ceptual gaps that hamper the design and evaluation of tDCS 
treatment protocols. In particular, there are currently no assays 
for assessing target engagement in tDCS studies, which makes it 
very difficult to discern the basis for therapeutic efficacy or lack 
thereof. This contrasts with drug development, where measures 
of target engagement are an essential and integral part of study 
design. In human studies, the in vivo assessment of drugs is criti-
cally dependent on proximal markers (e.g., receptor occupancy) 
as these enable a direct correlation between target engagement 
and measurements of drug efficacy or toxicity (6). In tDCS, 
target engagement depends on patient-specific factors related to 
head anatomy and functional state and on operator-controlled 
factors related to stimulation parameters (montage, current 
amplitude) and administration protocol (frequency and duration 
of treatment sessions) (7). In psychiatry, an additional challenge 
involves uncertainties in the definition of the target brain regions 
as a direct and consistent correspondence between symptoms and 
brain networks has yet to be established (8).
Here, we present an approach for the assessment of target 
engagement measures in tDCS studies of psychiatric symptoms. 
We focus on auditory verbal hallucinations (AVH) in patients with 
schizophrenia because the neural correlates of AVH are arguably 
better defined than those of other psychiatric symptoms. Current 
models of AVH propose a dual pathology involving reduced 
cognitive control due to hypofunction of prefrontal cortex 
(PFC) and abnormal activation of speech-related regions, in the 
superior temporal gyrus and temporoparietal junction (TPJ) 
(9, 10). This model has informed the tDCS montages that have been 
used to treat AVH that conventionally target these two regions. 
Despite initial positive results in case series and open label trials 
(Table S1 in Supplementary Material), randomized, double-blind, 
sham-controlled clinical trials (RCTs) have not been consistently 
differentiated between the active tDCS and the sham condition 
(11–15). Without methods to assess tDCS target engagement, it is 
difficult to interpret these results and improve study design.
In response, we outline an approach for improving the defini-
tion of the target network for AVH and for the assessment of two 
measures that could putatively provide a quantitative assessment 
of target engagement in tDCS. First, we identified the brain 
regions that comprise the AVH network using data from meta-
analyses of the relevant structural and functional imaging studies. 
Second, to accommodate concerns about anatomical variation, 
we prescribed the brain regions in the AVH network as regions 
of interest (ROIs) in a population-based standardized volume 
conductor head model and in four-head models from single 
individuals. We then used computational modeling to quantify 
two putative measures of target engagement, peak electric field 
strength, and percentage-modulated volume derived from three 
different tDCS protocols. Peak electric field strength in AVH-
network regions was chosen as it tracks cortical excitability in 
tDCS studies of motor regions (16, 17). We introduced modu-
lated volume as another potential index of target engagement. 
As AVH involve a network of brain regions (as opposed to a single 
region like the motor cortex), the efficacy of tDCS may depend 
on the percentage of the volume of the network being modulated. 
Our primary aim was to quantify the degree of engagement of 
the AVH network by different tDCS montages based on the peak 
electric field strength and percentage-modulated brain volume. 
Our secondary aim was to evaluate the degree of variation in 
these as a function of the anatomical variability of the head mod-
els used. For modulated volume, which is a non-linear measure, 
we also examined interindividual variability for each montage as 
a function of increasing current amplitude within the tolerable 
current range of 1–4 mA (18). Taken together, these steps outline 
a novel approach to the design of tDCS interventions for target 
identification and engagement that is image-guided, multi-target, 
and supports rational testing of therapeutic hypotheses.
MaTerials anD MeThODs
identification of the aVh network  
in the Brain
We interrogated databases available through the National Center 
for Biotechnology using relevant expanded subject headings and 
free text searches to identify meta-analyses of structural and 
functional neuroimaging studies of AVH published by February 
1, 2017. Coordinates of AVH correlates reported in Talairach 
space were transformed to Montreal Neurological Institute 
space, using the “tal2icbm_fsl” transform.1 All coordinates were 
mapped to the Automated Anatomical Labeling digital atlas (19) 
to identify anatomical regions of cross-modal convergence. The 
regions thus identified comprise the target regions of interest 
(AVH-ROIs) used in subsequent computational models.
Prescription of aVh-rOis in Population-
level and individual head Models
Based on the meta-analytic evidence described earlier, we pre-
scribed the AVH-ROIs identified in five previously developed 
three-dimensional (3D) realistic models of the human head 
(20–22). These comprised the New York Head (S1) and four head 
models belonging to single individuals (S2–S5). The New York 
Head (S1) is a publicly available standardized volume conductor 
head model (0.5 mm3 isotropic resolution) that was constructed 
using T1-weighted MRI scans of 152 adult human brains 
acquired at 0.5 mm3 isotropic resolution and segmented into 6 
tissue compartments comprising the skin, skull, cerebrospinal 
fluid (CSF), gray matter, white matter, and air cavities (20). The 
individual head models belonged to three men (S2, S3, and S4; 
aged 34–41 years) (21–23) and one woman (S5; aged 34 years) 
(22). They were generated from structural T1-weighted MRI scan 
with 1  mm3 isotropic resolution and segmented into the same 
six tissue compartments as the New York Head. These models 
are available upon request. For S2, individual tissue probability 
maps corresponding to gray matter, white matter, and CSF were 
automatically created using FAST (FMRIB Analysis Group, 
Oxford, UK) (24). The non-brain regions were semiautomatically 
segmented into three tissue compartments including skin, skull, 
and air using an in-house segmentation algorithm (21, 25–27), 
1 http://www.brainmap.org/icbm2tal/.
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followed by correction of segmentation errors using tools from 
ITK-SNAP (28). For S3–S5, automated segmentation was per-
formed using SPM (29), followed by correction of segmentation 
errors using an in-house MATLAB script (30) and ScanIP tools 
(Simpleware Ltd., Exeter, UK).
tDcs electrode Montages
The search space for optimal electrode placement in the treatment 
of AVH is too vast for systematic empirical evaluation. Taking a 
pragmatic approach, we focused on three montages: (A) a left 
unilateral (LUL) montage with anode over the left PFC (F3-FP1) 
and cathode over the left TPJ (P3), (B) a bilateral (BL) prefrontal 
1 × 1 montage with the anode over the left PFC (F3-FP1) and 
cathode over the right PFC (FP2), and (C) a third montage (2 × 1) 
with one anode over the left dorsolateral PFC (F3-FP1) and two 
cathodes, one on the left and the other on the right TPJ (T3-P3 
and T4-P4). The first two montages have been most widely used 
in tDCS studies (Tables S1 and S2 in Supplementary Material), 
while the third was included because of its theoretical potential to 
provide better target engagement of right-sided target AVH-ROIs.
electric Field computational Modeling
Computational modeling was performed separately for each of 
the three montages in each of the five head models. In addition, 
we assessed the effect of varying current amplitude across all three 
montages and head models within the range of 1–4 mA, which is 
known to be tolerable in humans (31). We used the same compu-
tational modeling approach based on our previous work (21, 26). 
The tDCS sponge electrodes were modeled with 5  cm  ×  7  cm 
surface intersecting the scalp. For each montage, the complete 3D 
head models incorporating the tDCS electrodes were adaptively 
tessellated to produce finite element models using the restricted 
Delaunay triangulation algorithm (32). The electric conductivities 
used for each tissue type across all five head models were as follows: 
gray matter = 0.33 S/m, white matter = 0.14 S/m, CSF = 1.79 S/m, 
skin = 0.43 S/m, skull = 0.0132 S/m, and air = 0 S/m (21, 23, 27, 
33, 34). The electrodes were assumed to have the conductivity of 
saline (1.4  S/m) (22). Constant electric current was applied to 
the electrode surfaces away from the head (26). The LUL and BL 
montages correspond to those that have been used in the current 
literature, and accordingly current intensity was set at 2  mA, 
unless otherwise stated (Table S1 in Supplementary Material). 
For the 2 × 1 montage, 2 mA was applied to the frontal anode 
and −1 mA to each of the posterior cathodes, unless otherwise 
stated. The electric field distribution was computed by solving 
the Laplace equation using the preconditioned conjugate solver 
within ANSYS (ANSYS Inc., Canonsburg, PA, USA) (21, 26). 
In addition, we modeled radial cortical electric field that rep-
resents the inward and outward component of the electric field 
relative to the cortical surface (22).
Data analysis
We computed the electric field magnitude (E) and the percent-
age modulated volume for each AVH-ROI. The modulated 
brain volume was defined as the percentage of the brain volume 
(within the left or right AVH networks) exposed to electric field 
magnitude (E) stronger than the modulation threshold (Eth), i.e., 
the volume where E/Eth ≥ 1 (21, 34). We acknowledge that the 
modulation threshold in living humans is yet to be conclusively 
determined. For these analyses, we used a published estimate 
of the modulation threshold (Eth = 0.2 V/m) based on previous 
evidence regarding the minimum electric field strength likely 
to change the firing rate of neurons in model in  vitro systems 
(35). Several studies have tried to define the minimum applied 
electric field sufficient to modulate transmembrane potential 
using different methodologies involving in vitro recordings from 
single neurons and brain slices and in vivo recordings in animals 
(36–38); the values reported in the case of direct current stimu-
lation ranged from 0.18 to 0.5 V/m, with 0.2 V/m being most 
commonly reported. We therefore chose this threshold which 
theoretically should yield the maximum modulated brain vol-
ume for each montage. Subsequently, interindividual variation in 
peak electric field strength and modulated brain volume across 
the five head models were determined using coefficient of varia-
tion (CV). To examine the effect on the modulated brain volume 
of altering the current amplitude, the electric field simulations 
for all montages were scaled linearly to span the range of 1–4 mA 
and the volume where E/Eth ≥ 1 was estimated for these ranges. 
Finally, we used analyses of variance, followed by Bonferroni-
corrected post  hoc pairwise comparisons, to determine if the 
peak electric field strength and modulated brain volume in the 
AVH-ROIs differed across the three tDCS montages. The effect 
size for the peak electric field strength and modulated brain 
volume between each pair of electrode montages was computed 
using the Cohen’s d (39).
resUlTs
identification and Prescription  
of the Target Brain network for aVh
We identified six meta-analyses that examined structural (40, 41) 
and functional differences in patients with AVH compared 
to healthy individuals (42–45). Details of the primary studies 
included in each meta-analysis are provided in Tables S3–S10 in 
Supplementary Material. Across all meta-analyses, brain regions 
consistently associated with AVH comprised the primary and 
secondary auditory cortex located in the superior temporal gyrus 
and in the Heschl’s gyrus; Broca’s and Wernicke’s area, respectively, 
located in the inferior frontal gyrus (pars opercularis and pars 
triangularis) and in the posterior superior temporal gyrus; the 
anterior cingulate gyrus; the somatosensory and motor cortices, 
respectively, located in the postcentral and precentral gyrus; the 
insula; and the hippocampus and the thalamus (Figure 1; Table 
S11 in Supplementary Material). Of note, most of the regions 
identified were BL (Table S11 in Supplementary Material). Based 
on these results, AVH-ROIs were prescribed in each of the five 
head models (Figure 1B).
effect of anatomic Variation and current 
amplitude on Peak electric Field strength
Figure 2 shows the simulated LUL, BL, and 2 × 1 tDCS configura-
tions. The spatial distributions of the electric field on the cortical 
surface and directional electric field normal to the cortical surface 
FigUre 1 | (a) Spatial distribution of the coordinates from meta-analyses of studies of patients with auditory verbal hallucinations (AVH) derived from Table S11 in 
Supplementary Material. Red = during AVH, green = during auditory or language tasks, and blue = morphometric studies. (B) Three-dimensional rendering of the 
brain regions of interest associated with AVH in a representative model. L, left.
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(inward and outward) are plotted for each modality in each 
individual. For each montage and each AVH-ROI, we estimated 
the mean peak electric field strength across the five head models. 
Figures  3A,B present the peak electric field strengths for each 
montage averaged across the five head models at the conventional 
2  mA current amplitude. Figures  3C,D present the CV of the 
peak electric field strength in each AVH-ROI across the five head 
models for each montage. The LUL 1 × 1 montage predominantly 
induced electric fields in the left hemisphere; the inward current 
flow occurred mostly through the left dorsolateral prefrontal 
cortex while the outward current flow occurred through the left 
temporoparietal and occipital regions. The BL prefrontal 1  ×  1 
montage generated comparable electric field magnitude in both 
hemispheres; the inward and outward flow occurred mostly 
over the prefrontal and frontal areas. The 2 × 1 montage induced 
electric fields in the left- and in the right-sided AVH-ROIs; the 
inward and outflow flow occurred over the frontal cortex and the 
temporoparietal regions, respectively.
We found significant differences in peak electric field strength 
across the three electrode montages (LUL, BL, and 2  ×  1) as 
shown in Table 1. Bonferroni-corrected pairwise comparisons 
showed the montages induced significantly different electric 
field strengths in several right-sided AVH-ROIs. Specifically, 
the BL montage generated higher peak electric field strengths 
in the right inferior frontal gyrus and insula than the other 
two montages (p < 0.001). The 2 × 1 montage produced higher 
peak electric field in the right postcentral gyrus than the others 
(p < 0.05).
effect of anatomic Variation and current 
amplitude on Percentage Modulated  
Brain Volume
Figure 4 shows the electric field maps relative to the threshold 
electric field (E/Eth) for current amplitudes in the range of 
1–4 mA for each montage. For each montage and each AVH-ROI 
in each head model, we estimated the percentage of modulated 
volume [i.e., percentage of the AVH network volume in which 
the electric field strength (E) was above 0.2 V/m]. We used the 
threshold 0.2 V/m as it is the postulated threshold for neuronal 
excitability (35). Figures 5A,B show the percentage modulated 
volume (E ≥ Eth) for each of the three montages for the left- and 
right-sided AVH-ROIs for current amplitudes ranging from 1 
to 4  mA averaged across the five head models. Figures  5C,D 
show the corresponding CV in the left- and right-sided AVH-
ROIs for each montage for current amplitudes ranging from 1 to 
4 mA. The corresponding data for each AVH-ROI are shown in 
Figures S1–S4 in Supplementary Material. Increasing the current 
amplitude increased modulated volumes and reduced interindi-
vidual variability, particularly for the LUL and 2 × 1 montages 
(Figures  4 and 5). Variability between montages reduced in 
general for current amplitudes above 3  mA. Nevertheless, we 
found significant differences in modulated volume across the 
three electrode montages (LUL, BL, and 2  ×  1) as shown in 
Table 2. The modulated brain volume in the left-side AVH-ROIs 
was significantly different across the montages for the range of 
2–4 mA at which lower modulated brain volume was produced 
FigUre 2 | Electric field modeling of transcranial direct current stimulation (tDCS) for three montages: (a) left unilateral 1 × 1 montage with F3-FP1 as the anode 
and T3-P3 as the cathode, (B) bilateral prefrontal 1 × 1 montage with F3-FP1 as the anode and FP2 as the cathode, and (c) 2 × 1 montage with F3-FP1 as the 
anode and cathodes at T3-P3 and T4-P4. First column shows tDCS electrode placements representing anode (red) and cathode (blue) electrodes in the New York 
head model (Subject 1; S1). Rows from top to bottom show electric field magnitude (E) and electric field normal to the cortical surface (En) for the models of 
Subjects 1–5 (S1–S5) at current amplitude of 2 mA.
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by the BL compared to the other two montages (p <  0.05). In 
contrast, the BL generated statistically higher modulated volume 
in the right-side AVH-ROIs than the other two montages at low 
current of 1 mA (p < 0.001).
DiscUssiOn
Here, we use AVH to illustrate the challenges in defining and 
assessing target engagement in the context of tDCS for psychiat-
ric disorders and to propose a strategy for the evaluation of tDCS 
protocols.
There are three main challenges. First, AVH arise from dys-
function in a brain network (Figure 1) rather than a single brain 
region which leads to uncertainty about which regions within 
the AVH-related network may constitute ideal targets for tDCS 
(46). Moreover, commonly used montages often target left-sided 
AVH-ROIs while evidence from the meta-analyses (Figure  1; 
Table S11 in Supplementary Material) and from individual 
studies point to additional involvement of right-sided brain 
regions to the pathophysiology of AVH (47–51). Second, there 
is inter-individual variability in brain structure and function 
in general (52) and in the AVH-related network in particular 
(50, 51). Individual differences in the spatial distribution of 
tDCS-induced electric fields may impact on the engagement of 
AVH-related regions and hence clinical response. Third, there is 
no behavioral, cognitive or neurophysiological measure that can 
be used to assess AVH-related neural changes during or following 
a single tDCS session, in contrast to electroconvulsive therapy 
(53) and repetitive transcranial magnetic stimulation (54) where 
seizure and motor excitability threshold can be, respectively, used 
as a threshold for titrating treatment.
In response to these uncertainties, we tested whether com-
putational modeling of electric field measures induced by tDCS 
can be meaningfully used to assess the engagement of the AVH 
FigUre 3 | (a) Regional electric field strength and spatial distribution at a current of 2 mA generated by each transcranial direct current stimulation montage in a 
representative head model. (B) Peak electric field magnitude at a current of 2 mA in each auditory verbal hallucinations (AVH) region of interest (ROI). Bars show 
mean values, and error bars show SD across the five head models for each target AVH-ROI. (c) Spatial distribution of the coefficient of variation (CV) of peak electric 
field magnitude in each target AVH-ROI across the five head models for each montage. (D) CV of the peak electric field magnitude in target AVH-ROI across the five 
head models for each montage. LUL, left unilateral 1 × 1 montage with F3-FP1 as the anode and T3-P3 as the cathode; BL, bilateral prefrontal 1 × 1 montage with 
F3-FP1 as the anode and FP2 as the cathode; 2 × 1, montage with one anode at F3-FP1 and cathodes at T3-P3 and T4-P4. IFGo, inferior frontal gyrus (pars 
opercularis); IFGt, inferior frontal gyrus (pars triangularis); ACG, anterior cingulate gyrus; PreCG, precentral gyrus; PoCG, postcentral gyrus; HES, Heschl’s gyrus; 
STG, superior temporal gyrus; HIP, hippocampus; INS, insula; THA, thalamus.
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FigUre 4 | Brain regions with electric field strength above the modulation threshold (0.2 V/m) in a representative model as a function of current amplitude. Spatial 
distribution of the electric field shown for the cortical surface and in a representative coronal slice for current amplitudes ranging from 1 to 4 mA for each montage. 
LUL, left unilateral 1 × 1 montage with F3-FP1 as the anode and T3-P3 as the cathode; BL, bilateral prefrontal 1 × 1 montage with F3-FP1 as the anode and FP2 as 
the cathode; 2 × 1, montage with one anode at F3-FP1 and cathodes at T3-P3 and T4-P4. R, right.
TaBle 1 | Differences in peak electric field strength for each region of interest in the auditory verbal hallucinations network across electrode montages.
laterality region analysis of variance
F (p-value)
Post hoc pairwise comparisons absolute effect size (cohen’s d)
lUl vs Bl lUl vs  
2 × 1
Bl vs  
2 × 1
L Inferior frontal gyrus, pars opercularis 1.55 (0.25) NS 1.19 0.03 0.88
L Inferior frontal gyrus, pars triangularis 3.89 (0.051) NS 1.84 0.36 1.17
L Anterior cingulate gyrus 5.30 (0.02) BL > LUL* 2.08 0.57 1.47
L Precentral gyrus 0.85 (0.44) NS 0.82 0.34 0.47
L Postcentral gyrus 0.27 (0.76) NS 0.45 0.09 0.33
L Heschl’s gyrus 6.64 (0.01) LUL > BL* 2.29 0.65 2.03
L Superior temporal gyrus 1.07 (0.37) NS 0.86 0.66 0.34
L Hippocampus 2.97 (0.08) NS 0.83 0.63 1.90
L Insula 1.39 (0.28) NS 0.81 0.17 1.14
L Thalamus 2.16 (0.15) NS 0.80 0.63 1.25
R Inferior frontal gyrus, pars opercularis 52.62 (1.14e−6) BL > LUL***; BL > 2 × 1*** 5.99 1.47 4.70
R Inferior frontal gyrus, pars triangularis 26.11 (4.25e−5) BL > LUL***; BL > 2 × 1*** 3.89 1.10 3.13
R Postcentral gyrus 12.48 (0.001) 2 × 1 > LUL*; 2 × 1 > BL*** 0.96 2.24 2.99
R Heschl’s gyrus 6.46 (0.01) BL > LUL* 2.30 1.29 0.91
R Superior temporal gyrus 5.67 (0.01) 2 × 1 > LUL* 0.67 1.75 1.60
R Insula 24.3 (6.03e−5) BL > LUL***; BL > 2 × 1*** 4.48 0.84 3.31
R Thalamus 0.79 (0.47) NS 0.70 0.07 0.83
Only results that survive Bonferroni correction for multiple comparisons are reported as significant; NS, non-significant; *p < 0.05; **p < 0.01; ***p < 0.001; LUL, left unilateral 
montage with anode over F3-FP1 and cathode over the left P3; BL, bilateral prefrontal montage with the anode over F3-FP1 and cathode over FP2; 2 × 1, one anode over the  
F3-FP1 and two cathodes, one over T3-P3 and the other over T4-P4; electrode placements are based on the International 10–20 system.
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network. We mined the available neuroimaging literature to 
define target ROIs implicated in AVH (Figure 1) and used com-
putational modeling approach to assess the engagement of these 
ROIs in five head models using the three different tDCS montages 
(Figure 2). The search space for optimal electrode placement in 
the treatment of AVH is too vast for empirical evaluation of brute 
force. Taking a pragmatic approach, we considered the LUL and 
BL prefrontal montages as these are most commonly used in the 
literature (Tables S1 and S2 in Supplementary Material). We also 
evaluated an experimental 2 × 1 montage, because of its theoreti-
cal potential to provide better target engagement of right-sided 
target AVH-ROIs. We used two measures of target engagement, 
FigUre 5 | Percentage modulated volume in (a) left-sided and (B) right-sided auditory verbal hallucinations (AVH) regions of interest (ROIs) across all head 
models for each of the three montages as a function of current amplitude. Coefficient of variation in percentage-modulated volume in (c) left-sided and  
(D) right-sided AVH-ROIs across all head models for each of the three montages. LUL, left unilateral 1 × 1 montage with F3-FP1 as the anode and T3-P3  
as the cathode; BL, bilateral prefrontal 1 × 1 montage with F3-FP1 as the anode and FP2 as the cathode; 2 × 1, montage with one anode at F3-FP1 and 
cathodes at T3-P3 and T4-P4.
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specifically peak electric field magnitude in each AVH-ROI and 
modulated brain volume of the AVH-network.
In terms of peak electrical field strength, the three montages 
differed only in a few right-sided AVH-ROIs. Specifically, the 
BL montage generated higher peak electric field strengths in the 
right inferior frontal gyrus and insula, while the 2 × 1 montage 
produced higher peak electric field in the right postcentral gyrus. 
Both of these regions have been associated with increased AVH 
frequency in patients who experience persistent AVH (44). The 
strength of the tDCS-induced electric field is a conventional 
measure of assessing the spatial distribution of the electric fields 
generated by different electrode configurations. However, its 
functional significance in terms of clinical efficacy has not been 
tested and is currently unknown. If we assume that peak electric 
field strength is associated with clinical efficacy, the current 
results suggest that the commonly used LUL montage is perhaps 
the least advantageous if one is interested in electrode montages 
that have the potential to modulate right-sided AVH-ROIs.
The three montages also differed in terms of modulated 
volume. In this case, however, differences were noted for the 
left-sided AVH network where both the LUL and 2 × 1 montages 
produced higher modulated volumes than the BL for currents 
ranging from 2 to 4 mA. As expected, the BL montage produced 
the highest focality within frontal regions due to the proximity 
of the electrodes (21). Consistent with previous findings (21), 
increasing the current amplitude increased modulated volume 
within AVH network. For the threshold-based modulated vol-
ume measure, variability between montages reduced in general 
for current amplitudes above 3  mA. Reduced interindividual 
variation at higher currents resulted from increased modulated 
volume within AVH network across multiple realistic head mod-
els. This is important for clinical applications, since it implies that 
increasing the current amplitude may be one possible option to 
overcoming anatomical variability and uncertainty about optimal 
electrode placement and potentially improve the efficacy of tDCS 
for AVH.
This study provides a computational evidence for two differ-
ent measures of target engagement that behave differently across 
different montages. There are other parameters in tDCS protocols 
involving duration of tDCS session, interval of administration, 
and length of trial (55) that may contribute to efficacy but could 
not be examined here. We did not address the issue of tolerability 
for higher current amplitudes although the excellent tolerability 
of tDCS allows optimism (18, 31, 56). Nevertheless, we have 
TaBle 2 | Differences in modulated brain volume for current amplitudes in the range of 1–4 mA for the left- and right-sided regions of interest (ROIs) in the auditory 
verbal hallucinations network across electrode montages.
current (ma) analysis of variance
F (p-value)
Post hoc pairwise comparisons absolute effect size (cohen’s d)
lUl vs Bl lUl vs 2 × 1 Bl vs 2 × 1
left auditory verbal hallucinations (aVh)-rOis
1 0.76 (0.49) NS 0.67 0.47 0.32
1.5 3.32 (0.07) NS 1.82 0.31 1.33
2 11.95 (0.001) LUL > BL**; 2 × 1 > BL** 3.07 0.05 2.91
2.5 21.01 (0.0001) LUL > BL***; 2 × 1 > BL*** 3.25 0.22 3.84
3 18.57 (0.0002) LUL > BL**; 2 × 1 > BL*** 2.75 0.24 3.07
3.5 9 (0.004) LUL > BL*; 2 × 1 > BL** 1.88 0.27 1.97
4 5.92 (0.01) LUL > BL*; 2 × 1 > BL* 1.53 0.20 1.56
right aVh-rOis
1 28.76 (2.6e−5) BL > LUL***; BL > 2 × 1*** 4.19 1.58 2.97
1.5 5.63 (0.01) BL > LUL* 2.08 1.06 1.10
2 2.01 (0.17) NS 1.40 0.93 0.12
2.5 2.16 (0.15) NS 0.81 1.12 0.66
3 1.58 (0.24) NS 0.58 0.97 0.66
3.5 2.17 (0.15) NS 0.58 1.20 0.92
4 1.88 (0.19) NS 0.53 1.14 0.90
Only results that survive Bonferroni correction for multiple comparisons are reported as significant; NS, non-significant; *p < 0.05; **p < 0.01; ***p < 0.001; LUL, left unilateral 
montage with anode over F3-FP1 and cathode over the left P3; BL, bilateral prefrontal montage with the anode over F3-FP1 and cathode over FP2; 2 × 1, one anode over the  
F3-FP1 and two cathodes, one over T3-P3 and the other over T4-P4; electrode placements are based on the International 10–20 system.
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provided a road map for the development of target engagement 
measures for tDCS that is based on neuroimaging evidence 
regarding the target networks and accommodates uncertainty 
about patient-specific abnormalities. This translational approach 
not only combines advances in computational modeling with 
knowledge gained from behavioral and functional neuroimaging 
studies regarding target definition and target engagement but 
also highlights knowledge gaps and points to avenues for future 
research.
Generally, the principled computational approach developed 
here could inform target engagement across tDCS application. 
Prior computational models typically considered electric field 
magnitude (or normal direction) in a single ROI. We show that 
consideration of multiple nodes in a functional network (based 
on imaging and trial meta-analysis) forces decisions on region 
stimulation and sparring that then suggest divergent optimal 
montages. The approach outlined here is particularly relevant for 
study designs that adopt the Research Domain Criteria (RDoC) 
framework.2 The RDoC initiative specifies neural circuits that 
may be theoretically and empirically linked to clinical symptoms 
and cognitive constructs. This framework therefore can be used 
to aid in the specification of target networks in future tDCS stud-
ies in neuropsychiatry. Moreover, considering a simple linear 
electric field (magnitude or normal) vs non-linear measures of 
ROI influence (such as our threshold-based volume measures) 
leads to different conclusion on the value of current intensity and 
best montage. As such, tDCS interventions rationalized based on 
computational modeling should be explicit about the underlying 
assumptions regarding network (dys)function and side effects 
(i.e., selection of target and avoid ROIs), biophysics of stimula-
2 https://www.nimh.nih.gov/research-priorities/rdoc/index.shtml.
tion (i.e., measure of ROI engagement), and goals (e.g., reduce 
interindividual variation).
Our approach also addresses issues relevant to personalized 
psychiatry because, as we have shown, individual variations in 
electrical field distribution in tDCS can be overcome by protocol 
modifications such as increasing the current amplitude to 4 mA.
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